Our Favorite Resources for
-
A nonprofit website dedicated to providing the most reliable and complete information available.
Breastcancer.org -
Provides educational materials, events, newsletters, a Young Survivors Network, and a toll-free helpline at 800-753-5222.
Living Beyond Breast Cancer -
A comprehensive site that offers a toll-free helpline (1-800-I'M AWARE), educational materials, advocacy, and fundraising events.
Susan G. Komen for the Cure
INFORMATION BY CANCER TYPE
Breast - More Stories
|
|
Dec 12, 2008Why one family is committed to educating the public about male breast cancer. |
|
Dec 12, 2008Breast Density Reduction Predicts Tamoxifen's Preventive Effect A brief from this year's San Antonio Breast Cancer Symposium discussing IBIS-1, a trial that examines tamoxifen's effectiveness as a breast cancer prevention drug, and how breast density is effected by Tamoxifen. |
|
|
Dec 12, 2008Oncotype DX predicts recurrence with aromatase inhibitor treatment A brief summarizing significant news from this year's San Antonio Breast Cancer Symposium regarding the TransATAC study's results showing that Oncotype DX may now be available for use in women who have taken aromatase inhibitors. |
|
|
Dec 12, 2008Zometa May Have Direct Effect on Breast Tumors A brief from this year's San Antonio Breast Cancer Symposium detailing research from the AZURE trial that indicates adding the drug Zometa to chemotherapy before surgery may help to shrink breast tumors by an additional third. |
|
|
Dec 12, 2008Remembering the People Behind the Data Advocate Joan Venticinque blogs about patient advocacy. |
|
|
Dec 12, 2008Living Well With Metastatic Breast Cancer CURE publisher Susan McClure blogs from a survivor's perspective. |
|
|
Dec 12, 2008Questions Emerge On Proper Use of Diagnostic Tools CURE Editor-in-Chief Debu Tripathy, MD, blogs on medical issues from SABCS. |
|
|
Dec 12, 2008A combination of two well known breast cancer drugs could prove very successful when treating hormone receptor-positive, HER2-positive metastatic disease. |
|
|
Dec 12, 2008Full-Time Advocate: Bringing SABCS cutting-edge information back home A look at how two-time breast cancer survivor Joan Venticinque got her start in advocacy and where she thinks the future may take her. |
|
|
Dec 12, 2008Data Confirms Zometa Reduces Bone Loss and Recurrence Risk A brief discussing findings from this year's San Antonio Breast Cancer Symposium showing that research suggests that the drug Zometa may provide patients with reduced bone loss and a lesser chance of recurrence. |
TEXT SIZE 